Rhino-Sino-Cerebral Mucormycosis Associated with Long-Term Rituximab Therapy in Multiple Sclerosis: A Case Report and Review of the Literature

Rhino-Sino-Cerebral Mucormycosis Associated with Long-Term Rituximab Therapy in Multiple Sclerosis: A Case Report and Review of the Literature

Rituximab is a CD20 depleting agent, widely used as an off-label disease- modifying treatment (DMT) in treating multiple sclerosis (MS). The present study aimed to report the first case of rhino-sino-cerebral mucormycosis in a patient with secondary progressive MS (SPMS), treated with rituximab.The...

Full description

Bibliographic Details
Main Authors: Mohsen Koosha, Golfam Mehrparvar, Sepideh Paybast
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2023-03-01
Series:Case Reports in Clinical Practice
Subjects:
Multiple sclerosis
Rituximab
B-Lymphocytes
Mucormycosis
Online Access:https://crcp.tums.ac.ir/index.php/crcp/article/view/728

Internet

https://crcp.tums.ac.ir/index.php/crcp/article/view/728

Similar Items